Clinical Trials in Houston

Showing 6341-6360 of 17,885 trials

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

NCT00835549

The objective of this study is to compare the relative bioavailability of cefdinir for oral suspension 250 mg/5mL (manufactured and distributed by TEVA Pharmaceuticals USA) with that of OMNICEF® for oral suspension, 250 mg/5mL (Abbott) in healthy, adult, non-smoking subjects under non-fasting conditions.

Healthy

Teva Pharmaceuticals USA32 participantsStarted Mar 2005

Houston, Texas, United States • Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions

NCT00835042

The objective of this study is to compare the relative bioavailability of Moexipril HCl/hydrochlorothiazide 15/25 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of UNIRETIC® 15/25 mg tablets (Schwartz Pharma) in healthy, adult non-smoking subjects under fasting conditions.

Healthy

Teva Pharmaceuticals USA60 participantsStarted Oct 2003

Saint Charles, Missouri, United States • Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Glimepiride 4 mg Tablets Under Non-Fasting Conditions

NCT00835172

The objective of this study is to compare the relative bioavailability of glimepiride 4 mg tablets (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by TEVA Pharmaceuticals USA) with that of AMARYL® tablets (Aventis) in healthy, adult, non-smoking subjects under non-fasting conditions.

Healthy

Teva Pharmaceuticals USA32 participantsStarted Mar 2003

Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions

NCT00834067

The objective of this study is to compare the relative bioavailability of moexipril HCl/ hydrochlorothiazide 15/25 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of UNIRETIC® 15/25 mg tablets (Schwartz Pharma) in healthy, adult, non-smoking subjects under non-fasting conditions.

Healthy

Teva Pharmaceuticals USA60 participantsStarted Oct 2003

Saint Charles, Missouri, United States • Houston, Texas, United States

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions

Glimepiride 4 mg Tablets Under Non-Fasting Conditions

Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions

Find Trials by Condition in Houston

Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)

Physiologic Pacing Registry

Finasteride 5 mg Tablets, Non-fasting

Leflunomide 20 mg Tablets, Non-Fasting

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions

Cefadroxil 500 mg Capsules Under Fasting Conditions

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)

Study of Selected X-linked Disorders: Goltz Syndrome

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women